MARKET

AMRN

AMRN

Amarin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.98
+0.06
+0.87%
Closed 19:37 07/06 EDT
OPEN
6.95
PREV CLOSE
6.92
HIGH
7.05
LOW
6.88
VOLUME
4.09M
TURNOVER
--
52 WEEK HIGH
26.12
52 WEEK LOW
3.950
MARKET CAP
2.69B
P/E (TTM)
-132.6996
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMRN stock price target is 16.80 with a high estimate of 51.00 and a low estimate of 8.00.

EPS

AMRN News

More
Amarin Corporation plc (NASDAQ:AMRN): Is Breakeven Near?
Simply Wall St. · 3d ago
Here’s what to do if the S&P 500 breaks out of its trading range
marketwatch.com · 4d ago
Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know
Zacks · 5d ago
Wall Street Has Given Up on These 2 Stocks, and That's a Huge Mistake
MotleyFool.com · 5d ago
Implied Volatility Surging for Amarin (AMRN) Stock Options
Zacks · 6d ago
Amarin (AMRN) Gains But Lags Market: What You Should Know
Zacks · 06/25 22:50
Resistance to the stock market’s rally is stiffening
marketwatch.com · 06/25 11:04
Edited Transcript of AMRN.OQ earnings conference call or presentation 30-Apr-20 11:30am GMT
Thomson Reuters StreetEvents · 06/23 22:34

Industry

Biotechnology & Medical Research
+0.67%
Pharmaceuticals & Medical Research
+0.72%

Hot Stocks

Symbol
Price
%Change

About AMRN

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
More

Webull offers kinds of Amarin Corporation plc (ADR) stock information, including NASDAQ:AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.